GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (MEX:MRNA) » Definitions » Other Gross PPE

Moderna (MEX:MRNA) Other Gross PPE : MXN29,726 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Moderna Other Gross PPE?

Moderna's Other Gross PPE for the quarter that ended in Mar. 2025 was MXN29,726 Mil.

Moderna's quarterly Other Gross PPE declined from Sep. 2024 (MXN48,162 Mil) to Dec. 2024 (MXN30,074 Mil) and declined from Dec. 2024 (MXN30,074 Mil) to Mar. 2025 (MXN29,726 Mil).

Moderna's annual Other Gross PPE declined from Dec. 2022 (MXN47,687 Mil) to Dec. 2023 (MXN35,799 Mil) and declined from Dec. 2023 (MXN35,799 Mil) to Dec. 2024 (MXN30,074 Mil).


Moderna Other Gross PPE Historical Data

The historical data trend for Moderna's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Other Gross PPE Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only 8,891.72 30,504.32 47,687.22 35,798.69 30,073.92

Moderna Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36,893.47 42,557.60 48,162.47 30,073.92 29,725.76

Moderna Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Moderna Business Description

Address
325 Binney Street, Cambridge, MA, USA, 02139
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.